Thrombosis warning in children suffering from henoch-schonlein purpura

Luan Li1, Jingwen Zhang, Yunying Zhang

  • 1Department of Dermatology and Venereology, First Affiliated Hospital, Dalian Medical University, Dalian, China.

Insights

Henoch-Schonlein Purpura (HSP), a common childhood vasculitis, can rarely lead to thrombosis. This case highlights the importance of monitoring high-risk children with HSP for this serious complication.

Area of Science:

  • Pediatric Rheumatology
  • Pediatric Vasculitis
  • Pediatric Thrombosis

Background:

  • Henoch-Schonlein Purpura (HSP) is the most prevalent form of childhood vasculitis.
  • Clinical features typically include purpura, arthritis, abdominal pain, and renal involvement.
  • Thrombosis is a recognized, albeit rare, complication of HSP.

Purpose of the Study:

  • To report a case of a 14-year-old boy with HSP and suspected superior mesenteric vein thrombosis.
  • To review existing literature on HSP-associated thrombosis.
  • To emphasize the need for vigilant monitoring of at-risk pediatric patients with HSP.

Main Methods:

  • Case presentation of a pediatric patient diagnosed with HSP and superior mesenteric vein thrombosis.
  • Comprehensive literature review of reported cases of thrombosis in Henoch-Schonlein Purpura.
  • Analysis of potential risk factors contributing to thrombosis in HSP patients.

Main Results:

  • The study identified one case of a 14-year-old boy with HSP and superior mesenteric vein thrombosis.
  • A review of the literature revealed eight previously reported similar cases.
  • The findings indicate a link between HSP and an increased risk of thrombosis.

Conclusions:

  • Henoch-Schonlein Purpura is associated with an increased risk of thrombosis.
  • Certain risk factors may predispose HSP patients to developing thrombosis.
  • Close monitoring of pediatric patients with HSP, particularly those at higher risk, is recommended to detect and manage thrombosis.

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...